1. Home
  2. LFVN vs KPTI Comparison

LFVN vs KPTI Comparison

Compare LFVN & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LFVN
  • KPTI
  • Stock Information
  • Founded
  • LFVN N/A
  • KPTI 2008
  • Country
  • LFVN United States
  • KPTI United States
  • Employees
  • LFVN N/A
  • KPTI N/A
  • Industry
  • LFVN Biotechnology: Pharmaceutical Preparations
  • KPTI Biotechnology: Pharmaceutical Preparations
  • Sector
  • LFVN Health Care
  • KPTI Health Care
  • Exchange
  • LFVN Nasdaq
  • KPTI Nasdaq
  • Market Cap
  • LFVN 188.1M
  • KPTI 103.5M
  • IPO Year
  • LFVN N/A
  • KPTI 2013
  • Fundamental
  • Price
  • LFVN $17.32
  • KPTI $0.64
  • Analyst Decision
  • LFVN Strong Buy
  • KPTI Strong Buy
  • Analyst Count
  • LFVN 1
  • KPTI 4
  • Target Price
  • LFVN $26.00
  • KPTI $5.00
  • AVG Volume (30 Days)
  • LFVN 91.8K
  • KPTI 1.0M
  • Earning Date
  • LFVN 01-28-2025
  • KPTI 11-05-2024
  • Dividend Yield
  • LFVN 0.93%
  • KPTI N/A
  • EPS Growth
  • LFVN 59.77
  • KPTI N/A
  • EPS
  • LFVN 0.32
  • KPTI N/A
  • Revenue
  • LFVN $196,014,000.00
  • KPTI $148,442,000.00
  • Revenue This Year
  • LFVN $4.36
  • KPTI $6.67
  • Revenue Next Year
  • LFVN $3.85
  • KPTI $8.58
  • P/E Ratio
  • LFVN $55.49
  • KPTI N/A
  • Revenue Growth
  • LFVN N/A
  • KPTI 1.77
  • 52 Week Low
  • LFVN $5.22
  • KPTI $0.63
  • 52 Week High
  • LFVN $18.41
  • KPTI $1.95
  • Technical
  • Relative Strength Index (RSI)
  • LFVN 66.83
  • KPTI 25.28
  • Support Level
  • LFVN $15.35
  • KPTI $0.75
  • Resistance Level
  • LFVN $18.41
  • KPTI $0.83
  • Average True Range (ATR)
  • LFVN 1.14
  • KPTI 0.05
  • MACD
  • LFVN 0.22
  • KPTI -0.01
  • Stochastic Oscillator
  • LFVN 82.14
  • KPTI 4.21

About LFVN Lifevantage Corporation (Delaware)

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.

Share on Social Networks: